+34 620 10 75 37info@nanbiosis.com

Posts Taged cell-therapy

You are here : Home / Posts Tagged "Cell therapy"

Best Emergeging Researcher Award in the Biomedical Area to Edorta Santos

Edorta Santos Vizcaíno has been awarded as Best Emerging Researcher in the biomedical area by the Bioaraba Health Research Institute in the XXII edition of the Research and Innovation Conference.

This award aims to recognize the work of researchers under the age of 40 who carry out their research activity in any public center of the Araba Health Network (OSI ARABA UNIVERSITY HOSPITAL / BIOARABA). The main award´’s criteria are the quality of the research carried out, active participation in public and private research projects, fidelity to the line of biomedical research and the usefulness and interest of the research developed for the environment are valued. The award also carries a financial endowment destined to continue promoting the research career of the awarded person.

Edorta Santos Vizcaíno (NANBIOSIS Unit 10 “Drug Formulation”) has a degree in Biochemistry and a doctorate in Pharmacy, with an international mention and an extraordinary award, from the UPV / EHU. He has been part of the research group NanoBioCel of the UPV / EHU, Consolidated Group of Excellence of the Basque university system, since 2006. In the same way, he is a member of the Center for Biomedical Research in Network for Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), a consortium dependent on the Carlos III Health Institute through the Ministry of Science and Innovation, and the Bioaraba Health Research Institute. Edorta has extensive experience in cell therapy and drug delivery systems. During the last years, his research has focused on the biomedical application of different biomaterials (for example, alginate, gelatin, collagen), mesenchymal stem cells (MSC) and their secretome (extracellular vesicles and soluble factors), in order to exert a immunomodulatory and regenerative effect in the treatment of immune-mediated inflammatory diseases (for example, inflammatory bowel disease, IBD) and the regeneration of chronic wounds, among other applications.

Bioaraba‘s mission is to develop research and innovation of excellence and quality that allows the translation of its results aimed at solving the health problems of the population, also promoting scientific research and for this, it annually carries out the Research and Innovation Conference.

• Read More

Results of the POSITION-II Project “A pilot line for the next generation of smart catheters and implants”

Cáceres, October 14th, 2021

POSITION II has received funding within the Electronic Components and Systems for European Leadership Joint Undertaking (ECSEL JU) in collaboration with the European Union’s H2020 Framework Programme (H2020/2014-2020) and National Authorities, under grant agreement Ecsel-783132-Position-II-2017-IA.

It promotes innovation in smart medical instruments and focuses in the next generation of smart catheters and implants by the introduction of open technology platforms for: miniaturization, in-tip AD conversion, wireless communication, MEMS transducer technology and encapsulation. These platforms are open to multiple users and for multiple applications.

POSITION II will enable the further development of the European R&D and manufacturing capability, not only encompassing the micro-fabricated device itself, but also the various value chains that they enable. Finally, by bringing smart catheters into the domain of high volume manufacturing, POSITION II will improve the quality of health-care at manageable cost.

The project, led by Philips Electronics Netherlands B.V, has been developed by 45 partners located in 12 different countries and has finished in September 2021. Within this large collaborative project, the NANBIOSIS units at CCMIJU have been involved in the validation of a novel catheter to administer encapsulated cell therapy to the heart. Also NANBIOSIS U10 Drug Formulation unit of CIBER-BBN and UPV/EHU , has participated being responsible for carrying out the formulation of the cells in hydrogels, for administration through the catheter at the cardiac level, for the regeneration of heart tissue.

The results of the project are available on a video-format documentary that contains short interviews to the consortium partners on their participation. Specifically, CCMIJU has presented its work and results through a short interview to Dr. Verónica Crisóstomo, Coordinator of Cardiovascular Unit. The documentary can be found at https://vimeo.com/604674309/bd8b94050c

Further info about the project here: http://position-2.eu/

• Read More

Online Course in Basic Procedures and Introduction to Mesenchymal Stem Cell Culture

From 30 August 2021 to 29 September 2021 Jesus Usón Minimally Invasive Surgery Centre (JUMISC) has organized an on line course on Procedures and Introduction to Mesenchymal Stem Cell Culture. The course is directected by Francisco Miguel Sánchez Margallo and run by researchers of NANBIOSIS U14 Cell Therapy Unit at JUMISC

Stem cells are cells capable of differentiating into a wide variety of cell types and can be isolated from different tissues. They have regenerative and anti-inflammatory properties thanks to the secretion of paracrine factors. Currently, these cells are being widely used in clinical trials for the treatment of different diseases such as Crohn’s disease, multiple sclerosis, diabetes, rheumatoid arthritis or myocardial infarction.

The objectives of this course is to teach the student to work in cell culture rooms, perform stem cell isolations, as well as the maintenance, expansion and conservation of these cell lines. You will also learn to characterize and differentiate these cell lines.

Once the course is finished, the student will be able to know the necessary equipment in a cell culture laboratory, the risks derived from working in these laboratories and the basic rules that must be taken into account to work in cell culture rooms. The student will also learn to prepare culture media, isolate stem cells from different tissues and everything necessary for the maintenance, expansion and conservation of cell lines. In addition, she will be able to acquire knowledge related to the differentiation protocols to different lineages: adipogenic, osteogenic and chondrogenic differentiation.

▶ DIRECTORS

Francisco Miguel Sánchez Margallo
Scientific Director of CCMIJU / Deputy Scientific Director of NANBIOSIS

Esther Lopez Nieto
Researcher at the Cell Therapy Unit of NANBIOSIS of the JUMISC

▶ TEACHERS

Dr Javier García Casado.
Scientific Director of NANBIOSIS U14 Cell Therapy Unit Postdoctoral researcher at the Cell Therapy Unit of the JUMISC

Dr Esher López.
Researcher at the Cell Therapy Unit of the JUMISC / NANBIOSIS

Federica Marinaro.
Researcher at the Cell Therapy Unit of the JUMISC / NANBIOSIS

Mª de los Angeles de Pedro
Researcher at the Cell Therapy Unit of the JUMISC / NANBIOSIS

Maria Pulido
Researcher at the Cell Therapy Unit of the JUMISC / NANBIOSIS

Veronica Alvarez.
JUMISC Superior Laboratory Technician

Information and enrollment here

• Read More